More Globe Newswire

View Older Stories View Newer Stories

Feb 26, 2024 08:00AM PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
Feb 26, 2024 08:00AM Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
Feb 26, 2024 08:00AM Mission Produce™ to Release Fiscal First Quarter 2024 Financial Results on Monday, March 11, 2024
Feb 26, 2024 08:00AM Monarch Private Capital Finances the Rehabilitation of Historic Landmark in New Orleans
Feb 26, 2024 08:00AM Great Pacific Gold Commences Drilling to Follow Up on Recent High-Grade Comet Discovery
Feb 26, 2024 08:00AM LifeMD to Report Fourth Quarter 2023 Financial Results on March 11
Feb 26, 2024 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
Feb 26, 2024 08:00AM Doug Bruder Joins ARA as Director, National Security Programs
Feb 26, 2024 08:00AM L7 Global Public Beta Progressing Smoothly: An Overview of New Functions and Features
Feb 26, 2024 08:00AM Mizuho Welcomes 2023 Mizuho Americas Open Champion Rose Zhang as Brand Ambassador
Feb 26, 2024 08:00AM Scaling New Heights: DeFiQuant's Crypto Bot Sets Benchmark for Automated Trading
Feb 26, 2024 08:00AM Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Feb 26, 2024 08:00AM Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
Feb 26, 2024 08:00AM INNOVATE Corp. Announces Rights Offering for Common Stock
Feb 26, 2024 08:00AM Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference
Feb 26, 2024 08:00AM BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
Feb 26, 2024 08:00AM Perspective Therapeutics to Participate at Upcoming Investor Conferences
Feb 26, 2024 08:00AM SIMONE BILES, JAMAL MURRAY AND COCO GAUFF LEAD THE NOMINATIONS FOR 2024 LAUREUS WORLD SPORTS AWARDS
Feb 26, 2024 08:00AM Lirum Therapeutics Presents Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy, at the 2024 ESMO Targeted Anticancer Therapies Congress; Highlighting LX-101’s Potential in IGF-1R Promi
Feb 26, 2024 08:00AM Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Feb 26, 2024 08:00AM Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
Feb 26, 2024 08:00AM Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over
Feb 26, 2024 08:00AM Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Feb 26, 2024 08:00AM NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March
Feb 26, 2024 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Feb 26, 2024 08:00AM Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution
Feb 26, 2024 08:00AM Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
Feb 26, 2024 08:00AM Interstellar Communication Holdings Welcome New Board Member
Feb 26, 2024 08:00AM Monarch Private Capital Finances the Rehabilitation of Historic Landmark in New Orleans
Feb 26, 2024 08:00AM Lightspeed to Participate in Upcoming Investor Conferences
Feb 26, 2024 08:00AM KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
Feb 26, 2024 08:00AM Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
Feb 26, 2024 08:00AM Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Feb 26, 2024 08:00AM Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
Feb 26, 2024 08:00AM Disclosure of trading in own shares from February 19, 2024 to February 23, 2024
Feb 26, 2024 08:00AM Velcan Holdings: Share buyback program - weekly statement
Feb 26, 2024 08:00AM MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
Feb 26, 2024 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Feb 26, 2024 08:00AM ASML reports transactions under its current share buyback program
Feb 26, 2024 08:00AM eQ Plc has released the 2023 Annual Report
Feb 26, 2024 08:00AM red violet to Announce Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
Feb 26, 2024 07:58AM Microchip Launches New dsPIC® DSC-Based Integrated Motor Drivers that Bring Controllers, Gate Drivers and Communications to a Single Device
Feb 26, 2024 07:58AM Save Foods Navigates Brazilian Regulation and Commences Commercial Activity Through Exclusive Local Distributor
Feb 26, 2024 07:53AM iZIP.AI Unveils Groundbreaking AI Crypto Chatbot, Automated Trading Signals, and Comprehensive Market Analysis Platform
Feb 26, 2024 07:53AM iZIP.AI Unveils Groundbreaking AI Crypto Chatbot, Automated Trading Signals, and Comprehensive Market Analysis Platform
Feb 26, 2024 07:52AM Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings Plc
Feb 26, 2024 07:50AM Fairfax Announces Acquisition of Additional Orla Shares
Feb 26, 2024 07:45AM New Journey in Compliance: BAORUI Proudly Acquires the US MSB License, Marking a Financial Milestone
Feb 26, 2024 07:45AM Trailbreaker Resources Expands Land Package and Receives Drill Permit for Liberty Copper Property
Feb 26, 2024 07:45AM iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
View Newer Stories View Older Stories